Acute type B aortic dissection (adult)
Ascending aorta not involved (Stanford B, DeBakey III). Manage with an aortic team; transfer to an aortic centre.
Type B Aortic Dissection Management (ESC 2024, EACTS-endorsed): Acute type B aortic dissection (adult) → Confirm with CT angiography; check for shock fi...
Pathway Overview
20 steps
20 total
Ascending aorta not involved (Stanford B, DeBakey III). Manage with an aortic team; transfer to an aortic centre.
ECG-gated CT angiography, neck to pelvis. Unstable or CT not possible: TOE. Do not delay treatment for results.
SBP <90 mmHg or shock in type B dissection usually means rupture. Resuscitate, call the aortic team now and go to emergency repair (complicated step).
These change BP targets, drugs and the type of repair.
Target SBP <120 mmHg and HR <=60 bpm, or the lowest BP that keeps organ perfusion. IV opioid, titrated to pain.
Complicated = any of: rupture (contained or free), malperfusion (mesenteric, renal, limb, spinal cord), extension or rapid enlargement on repeat imaging, refractory pain >12 h, or hypertension despite more than 3 drug classes.
Emergency intervention is recommended. Continue anti-impulse therapy; accept a higher BP if malperfusion.
Suitable = adequate proximal and distal landing zones and iliofemoral access.
Aim: restore true-lumen flow, relieve malperfusion, promote false-lumen thrombosis.
Antihypertensive therapy for all patients with type B dissection.
Use MRI where possible in young patients to reduce radiation, and when frequent scans are needed after the first year.
Check at each scan and visit. Progression = new symptoms, malperfusion, rapid growth or diameter >=55 mm.
Up to half of patients develop aneurysmal change. Chronic dissection: open repair first-line if low risk or heritable disease; TEVAR for other eligible patients.
Imaging for life. After TEVAR: 1, 6 and 12 months, then yearly. After open repair: CT and echo within 6 months, CT at 12 months, then yearly.
Keep imaging for life; the distal false lumen often stays patent.
Open graft replacement via left thoracotomy in an aortic centre, with spinal cord protection.
Medical therapy is the initial treatment. Continue anti-impulse therapy and analgesia.
Any of: aortic diameter >40 mm, false lumen >20-22 mm, entry tear >10 mm or on the inner curve, growth >5 mm on serial imaging, partial false-lumen thrombosis, haemorrhagic pleural effusion, radiological malperfusion, readmission or recurrent pain.
Subacute-phase TEVAR to prevent aortic complications, if anatomy is suitable and life expectancy >5 years.
Continue optimal medical therapy. Recheck for complications and high-risk features on each scan.
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases (Mazzolai et al., Eur Heart J 2024;45:3538-3700), endorsed by EACTS; section 9.3.1.4 type B aortic dissection
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
Contraindicated Populations
Applicable Regions
AU: No IV diltiazem on the ARTG: use IV verapamil when a beta-blocker is contraindicated. Vasodilator example is glyceryl trinitrate (available in Australia); otherwise follow the local vasodilator protocol.
EU: ESC 2024 (endorsed by EACTS): acute HR <=60 bpm with SBP <120 mmHg; long-term SBP 120-129 mmHg if tolerated. EACTS/STS 2024: acute SBP 100-120 mmHg with HR 60-80 bpm.
US: ACC/AHA 2022: acute HR target 60-80 bpm with SBP <120 mmHg; long-term BP <130/80 mmHg.
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
The Type B Aortic Dissection Management (ESC 2024, EACTS-endorsed) is a emergency clinical algorithm for Cardiothoracic Surgery. It provides a structured decision tree to guide clinical decision-making, based on 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases (Mazzolai et al., Eur Heart J 2024;45:3538-3700), endorsed by EACTS; section 9.3.1.4 type B aortic dissection.
This algorithm is based on 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases (Mazzolai et al., Eur Heart J 2024;45:3538-3700), endorsed by EACTS; section 9.3.1.4 type B aortic dissection (DOI: 10.1093/eurheartj/ehae179).
Known limitations include: Adults with acute type B dissection only; not for intramural haematoma or penetrating ulcer. TEVAR versus open repair, and repair timing, are aortic-team decisions.; No specific advice for cocaine- or methamphetamine-associated dissection: ESC 2024 and ACC/AHA 2022 give none. Get specialist advice before beta-blockade.; Pre-emptive TEVAR for high-risk uncomplicated dissection rests on limited trial data (INSTEAD-XL, ADSORB); high-risk definitions differ between guidelines.; Follows ESC 2024. EACTS/STS 2024 differs: acute SBP 100-120 mmHg and HR 60-80 bpm; repair of chronic dissection at >=55 mm (Class I).; Surveillance follows the ESC 2024 schedule; aortic centres may adapt it.; Medical therapy success depends on long-term adherence.. Individual patient factors may require deviation from these recommendations.
In AttendMe.ai, the Type B Aortic Dissection Management (ESC 2024, EACTS-endorsed) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free